Drug Company Commits $200-Million to Improve Global Health

Johnson & Johnson, the pharmaceutical company, announced today that it will commit $200-million over five years to improve the health of women and children in poor countries.

Three-quarters of the commitment from the company, in New Brunswick, N.J., will be in the form of cash grants to nonprofit organizations; the rest will be medicines and other supplies.